FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 68907

News■ Unclear/unknown

Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026

KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 11:00 UTC
LAST UPDATE2026-10-07 11:00 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

Late-stage data presentations are catalysts for a small-cap biotech but no results are given.

Kodiak readouts loom at AAO 2026
CATALYST TO WATCH

Phase 3 DAYBREAK and GLOW2 data

MAIN RISK

Negative data would hit the stock hard

FULL DISPATCH

First scientific presentation of Phase 3 DAYBREAK results for Zenkuda and tabirafusp-ted in wet age-related macular degeneration scheduled for AAO 2026. Additional presentations include Phase 3 GLOW2 data for Zenkuda in diabetic retinopathy and Phase 1b APEX data for KSI-101 in macular...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · PRIMARY2026-10-07 11:00 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.